Baldwin Wealth Partners’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-400
Closed -$13K 662
2021
Q3
$13K Hold
400
﹤0.01% 495
2021
Q2
$17K Hold
400
﹤0.01% 485
2021
Q1
$20K Buy
+400
New +$20.9K ﹤0.01% 461

Other funds holding DMTK

Baldwin Wealth Partners's DMTK Position: Q4 2021 in Review

Baldwin Wealth Partners sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2021, closing a stake of 400 shares — an estimated $13K sold.

Baldwin Wealth Partners first reported a position in DMTK in Q1 2021 and held it in 3 quarters. The position peaked at $20K in Q1 2021. 143 funds tracked by Wall St. Rank hold DMTK as of Q4 2021.

  • Baldwin Wealth Partners reported no remaining DermTech, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Baldwin Wealth Partners sold 400 DermTech, Inc. Common Stock shares in Q4 2021, an estimated $13K.
  • Baldwin Wealth Partners first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • Baldwin Wealth Partners's DermTech, Inc. Common Stock position peaked at $20K in Q1 2021.
  • 143 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2021.

Based on Baldwin Wealth Partners's 13F filing for Q4 2021, filed 14 Jan 2022.